Why the Authors Use Cardiac Resynchronization Therapy with Defibrillators - 20/12/17
Résumé |
Cardiac resynchronization therapy (CRT) improves left ventricular function, especially in patients with left bundle branch block or those receiving chronic right ventricular pacing. CRT is typically accomplished by placing a right ventricular endocardial pacing lead and a left ventricular pacing lead via the coronary sinus to a coronary vein overlying the lateral or posterolateral left ventricle. CRT can be combined with an implantable defibrillator or with a pacemaker. Limited data are available to compare these two versions of CRT head to head. This review summarizes the relevant trials and meta-analyses regarding these two forms of CRT.
Le texte complet de cet article est disponible en PDF.Keywords : Cardiac resynchronization therapy, Heart failure, Systolic, Defibrillators, Implantable, Death, Sudden
Plan
| This article originally appeared in Cardiac Electrophysiology Clinics, Volume 7, Issue 4, December 2015. |
|
| E. Sze reports a pending research grant with Medtronic > $10,000. J.P. Daubert reports the following relationships with industry: (1) research grants to Duke University from Biosense Webster, Medtronic, Boston Scientific, and Gilead (all are >$10,000); (2) honoraria for lectures, advisory board, or consultation from ARCA Biopharma, Biosense-Webster, Biotronik, Boston Scientific, Cardiofocus, Gilead, Medtronic, Orexigen, St. Jude, and Vytronus (all are <$10,000); (3) fellowship support to Duke University provided by Biosense-Webster, Boston Scientific, Medtronic, and St. Jude (all are >$10,000). |
Vol 13 - N° 1
P. 139-151 - janvier 2017 Retour au numéro
Article précédent
- Cardiac Resynchronization Therapy : An Overview on Guidelines
- Giuseppe Boriani, Martina Nesti, Matteo Ziacchi, Luigi Padeletti
- Why We Have to Use Cardiac Resynchronization Therapy–Pacemaker More
- Jean-Claude Daubert, Raphaël Martins, Christophe Leclercq
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?